-
-
-
-
-
-
-
Lucid Capital Markets Downgrades Passage Bio Inc. (PASG) to Neutral
-
-
-
-
-
-
-
Passage Bio announces 1-for-20 reverse stock split effective July 14
-
-
-
-
-
-
-
Passage Bio (PASG) Presents Preclinical and Interim Clinical Data for PBFT02 in FTD-GRN
-
-
-
-
-
425,071 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

